Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2014

Oct 1, 2014

5262_dirs_2014-10-01_b0e41087-96b6-4247-84b4-699bc2a3a963.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1996T

GlaxoSmithKline PLC

01 October 2014

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc (GSK) was advised on 1 October 2014, that on 30 September 2014 the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.22 per Ordinary Share, and notional ADSs at a price of $46.31 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2014 to 30 September 2014:

Non Executive Director Ordinary Shares American Depositary Shares (ADSs)
Sir Christopher Gent 4,395.218
Professor Sir Roy Anderson 505.450
Dr Stephanie Burns 633.729
Stacey Cartwright 373.594
Lynn Elsenhans 1,140.713
Judy Lewent 491.686
Sir Deryck Maughan 1,529.691
Dr Daniel Podolsky 1,147.268
Tom de Swaan 461.498
Jing Ulrich 316.865
Hans Wijers 373.594

V A Whyte

Company Secretary

1 October 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFBZBFBFBE